47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
78.30.Z - Employment activities
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,7 | 0,9 | 0,9 | -4,5 |
Gross profit (loss) | 1,1 | 0,9 | 0,9 | 0,2 |
EBITDA | 1 | 0,8 | 0,9 | 3,8 |
Short time liabilities | 3,8 | 3,6 | 3,2 | -10,4 |
Other operating costs | 0,1 | 0,1 | 0 | -77,4 |
Equity capital | 0,3 | 0,1 | 0,3 | 263,7 |
Operating profit (EBIT) | 1 | 0,8 | 0,9 | 2,3 |
Assets | 4,5 | 4 | 3,9 | -1,6 |
Net profit (loss) | 1,1 | 0,9 | 0,9 | 0,2 |
Cash | 0,7 | 0,6 | 0,6 | -0,1 |
Net income from sale | 23,6 | 25,9 | 27,1 | 4,6 |
Liabilities and provisions for liabilities | 4,1 | 3,9 | 3,7 | -6,5 |
Working assets | 4,5 | 3,5 | 3,9 | 12,5 |
Other income costs | 0,5 | 0,1 | 0 | -78,6 |
Depreciation | 0 | 0 | 0 | 500 |
% | % | % | p.p. | |
Profitability of capital | 343,6 | 1196,8 | 329,6 | -867,2 |
Equity capital to total assets | 6,9 | 1,8 | 6,7 | 4,9 |
Gross profit margin | 4,5 | 3,4 | 3,2 | -0,2 |
EBITDA Margin | 4,4 | 3,3 | 3,2 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 58 | 51 | 44 | -7 |
Current financial liquidity indicator | 1.183029294013977 | 0.9660694599151611 | 1.2123031616210938 | 0,2 |
Net dept to EBITDA | -0.3268556296825409 | -0.6090289354324341 | -0.7111523747444153 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane